Pricing Log in Create free account

Monopar Therapeutics Inc. (MNPR) vs Shattuck Labs, Inc. (STTK)

Monopar Therapeutics Inc. and Shattuck Labs, Inc. are both Biotechnology companies. Monopar Therapeutics Inc. and Shattuck Labs, Inc. are of similar size ($451.2M and $450.6M). Across the 9 metrics below, Monopar Therapeutics Inc. leads on 7 and Shattuck Labs, Inc. on 2.

Valuation

Metric MNPR STTK Biotechnology median
P/E n/m n/m 10.60
P/S n/m 106.26 9.40
P/B 4.66 2.82 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 69.10 9.02
Earnings yield (3.04%) (11.11%) (32.88%)
Free cash flow yield (2.00%) (6.92%) (23.13%)

Profitability

Metric MNPR STTK Biotechnology median
Gross margin — 100.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (19.50%) (39.21%) (51.96%)
Return on assets (18.90%) (36.88%) (46.06%)
Return on invested capital 0.00% (1,230.74%) 0.00%

Growth

Metric MNPR STTK Biotechnology median
Revenue growth (TTM) — 106.48% 6.76%
EPS growth (last fiscal year) 54.99% 53.02% 29.88%
Revenue growth, 5-year CAGR — (36.82%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MNPR STTK Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 33.56 27.59 4.97
Net debt to EBITDA 8.06 1.62 1.01

Dividend

Metric MNPR STTK Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric MNPR STTK Biotechnology median
Market cap 451.19m 450.63m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack